A neural survival factor is a candidate oncogene in breast cancer
Dale Porter, Kornélia Polyák(Dana-Farber Cancer Institute), Jeffrey R. Marks(Duke Medical Center), Jaana Lahti‐Domenici(Dana-Farber Cancer Institute), Ana Merlos-Suarez(Johns Hopkins University), Edward Gabrielson(Johns Hopkins University), Koei Chin(Oregon Health & Science University), Rebecca Gelman(Dana-Farber Cancer Institute), Young Kyung Bae(Johns Hopkins University), Jennifer A. Chan(University of Calgary), Aparna Keshaviah(Dana-Farber Cancer Institute), Constance L. Monitto(Johns Hopkins University), Cynthia C. Morton(Brigham and Women's Hospital), Pankaj Seth(Boston Children's Hospital), Christine M. Hulette(Duke University), Mabel P. Duyao(Massachusetts General Hospital), Ralph H. Hruban(Johns Hopkins University), Andrea L. Richardson(Brigham and Women's Hospital), Stanislawa Weremowicz(Brigham and Women's Hospital)
Cited by 132
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k